Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery | More News pipelinereview.com Artificial Intelligence by Saeed - January 10, 2020 0 Source Tags: agreement, business, collaboration, deal, financial, Licensing, management, merger & acquisition, sales, strategy Choose your Reaction! 0 0 0 0 0 0 0
